Jim Nissel

Executive Director - Clinical Scientists, Early Development

Role
Executive Director Clinical Scientists, Early Clinical Development at Bristol Myers Squibb
Location
Summit, NJ, US
LinkedIn followers
500 followers

About Jim Nissel

I am currently leading a department of Early Development Clinical Scientists and Quality Review Specialists, encompassing Immunology, Cardiovascular, and Neuroscience Assets. Bristol Myers Squibb (formerly Celgene Corporation) Dec 2008 - present - Executive Director – Head of Clinical Scientists, Early Drug Development Immunology, Cardiovascular, Neuroscience May 2022 - present - Senior Director/Head of Clinical Scientists, Clinical Pharmacology and Dec 2019 - Apr 2022 Early Development Immunology, Cardiovascular, Fibrosis, Neuroscience - Senior Director, Trial Management, Translational Development – Clinical Pharmacology Nov 2018 - Nov 2019 - Director, Trial Management, Translational Development – Clinical Pharmacology Oct 2015 - Oct 2018 - Associate Director, Trial Management, Translational Development – Clinical Pharmacology Dec 2008 - Sep 2015

Experience

  1. Executive Director Clinical Scientists, Early Clinical Development

    Bristol Myers Squibb

    May 2022 — Present · Summit, NJ, US

    Manage a department of 14 Clinical Scientists and 4 Document Quality Review Specialists • Provide scientific and clinical leadership to multiple functions; provide program and study therapeutic area skills training • Maintain an advanced understanding of the status of all Asset Programs within the Early Development portfolio, and contribute to Clinical Development Plans and Asset Program prioritizations • Define and standardize best practices and development opportunities for the Clinical Scientist function• Contribute to development and implementation of resource algorithm for Clinical Scientist function • Manage resource allocation and provide input to department budget • Serve as a key cross-functional collaborator; represent the Early Development Clinical Scientist function • Lead risk identification and mitigation teams • Lead and collaborate on multiple internal initiatives (eg, protocol development, vendor identification and management, clinical development plans, data management, etc) • Authoring and/or reviewing abstracts, presentations, and manuscripts for external publications• Due diligence activities to ensure proactive identification and remediation of clinical issues

Education

  • University of Maryland Baltimore County

    Bachelor of Science, Emergency Health Services, Management

  • Saint Elizabeth University

    Master of Science Management , Pharmaceutical Research and Development

    2003 — 2006

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jim Nissel — Executive Director Clinical Scientists, Early Clinical Development at Bristol Myers Squibb in Summit, NJ, US | Unifers